Kochak G M, Rakhit A, Thompson T N, Hurley M E
Pharmaceuticals Division, CIBA-GEIGY Corporation, Ardsley, New York 10502.
J Clin Pharmacol. 1988 Mar;28(3):222-7. doi: 10.1002/j.1552-4604.1988.tb03136.x.
The interactive effects of the coadministration of steady-state cimetidine and single-dose pentopril, an angiotensin converting enzyme inhibitor, on the pharmacokinetic disposition of each other were studied in humans. Cimetidine reduced the clearance of pentopril by 11 to 14%. This reduction in clearance was shown to be caused by a reduction in liver blood flow probably mediated through H2 receptor blockade. Meanwhile pentopril induced the oral clearance of cimetidine by 21%, presumably by a reduction in the bioavailable fraction of cimetidine. The mechanism of this interaction is unknown.